Innovid Corp. received a notice from the NYSE for non-compliance with Section 802.01C due to its average closing price being below $1.00 per share over a 30 trading-day period. This may negatively impact the stock price in the short term as investors may perceive it as a sign of financial instability. However, the company plans to cure the deficiency and return to compliance within a six-month period, which may mitigate the negative impact over time.